Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Iu B, Kochkareva"'
Publikováno v:
Terapevticheskii arkhiv. 82(2)
The use of imatinib mesylate (Glivec) (Novartis Pharma AG, Switzerland) that is the drug of choice in treating patients with chronic myeloid leukemia (CML) has increased 7-year survival and improved the prognosis of the disease. The drug is generally
Publikováno v:
Klinicheskaia meditsina. 84(9)
The dynamics of free radical and peroxidation processes in patients with non-Hodgkin lymphomas (NHL) was studied parallel to the evaluation of changes in the functional condition of the cardiovascular system during a course of chemotherapy. Thirty-on